H Lawnicka Selected Research

BIM 23120

3/2007

Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Lawnicka Research Topics

Disease

2	Adenoma (Adenomas) 01/2011 - 03/2007
2	Neoplasms (Cancer) 01/2011 - 03/2007
1	Infections 06/2012
1	Hyperprolactinemia 06/2012
1	Hyperaldosteronism (Conn Syndrome) 01/2011
1	Pheochromocytoma 01/2011
1	Adrenal Gland Neoplasms (Adrenal Cancer) 10/2009
1	Adrenocortical Carcinoma 10/2009
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2007

Drug/Important Bio-Agent (IBA)

2	ProlactinIBA 06/2012 - 03/2007
1	OsteopontinIBA 01/2011
1	EndostatinsIBA 01/2011
1	AcidsIBA 10/2009
1	LactonesIBA 10/2009
1	L 783277IBA 10/2009
1	BIM 23926IBA 03/2007
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2007
1	Growth Hormone (Somatotropin)IBA 03/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2007
1	Dopamine (Intropin)FDA LinkGeneric 03/2007
1	GonadotropinsIBA 03/2007
1	BIM 23206IBA 03/2007
1	BIM 23120IBA 03/2007
1	Chromogranin AIBA 03/2007

Therapy/Procedure

1	Adrenalectomy 01/2011